申请人:Rhone-Poulenc Industries
公开号:US04124596A1
公开(公告)日:1978-11-07
Compounds of the formula: ##STR1## wherein R represents hydrogen or an alkyl radical, R.sub.1 represents a hydroxy, amino or alkoxy radical or an alkylamino or dialkylamino group, the various alkyl radicals and the alkoxy radical being optionally substituted by a dialkylamino group, the alkyl radicals of the said dialkylamino groups optionally being linked together to form a heterocyclyl radical with 5 or 6 atoms in the ring, and A represents the thieno[2,3-b]thien-2-yl or thieno[3,2-b]thien-2-yl radical, the A--CO-- grouping being attached to the 3- or 4-position of the phenyl ring, have been found to possess useful pharmacological properties and are particularly active as analgesics, antipyretics, agents for inhibiting platelet aggregation and as anti-inflammatory agents.
式如下:##STR1## 其中R代表氢或烷基基团,R.sub.1代表羟基、氨基或烷氧基或烷基氨基或二烷基氨基团,各种烷基基团和烷氧基基团可以选择地被二烷基氨基团取代,所述二烷基氨基团的烷基基团可以选择地连接在一起形成含有5或6个原子的杂环基团,A代表噻吩[2,3-b]噻吩-2-基或噻吩[3,2-b]噻吩-2-基团,A--CO--基团连接到苯环的3-或4-位置,已发现具有有用的药理特性,并且作为镇痛剂、退热剂、抑制血小板聚集剂和抗炎药物特别活跃。